Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Sort 378 results by:

Filter Applied. Clear All
Reset All Filters

Search Results for: Covid vacc /page/2/about:blank

The Treatment of Human Embryos Created through IVF: The U.S. and 15 Selected Countries’ Regulations

This paper examines the present status of in vitro fertilization laws, regulations, and guidelines in a sampling of countries. While countries like Italy, Germany, and Poland have regulated IVF in a way that attempts to protect human life in its earliest stages, the United States has virtually no IV...

Legacy Giving

No-Test Chemical Abortion Provision: Can it be Justified?

Many undocumented assumptions have been made to portray unsupervised, “self-managed” medical abortion as safe. These erroneous conclusions will, in fact, cause the procedure to become more dangerous for a woman seeking abortion, and will be addressed below.

The Impact of Chemical Abortion by Mail

Due to the COVID-19 pandemic, the U.S. abortion industry has undergone significant changes. The Food and Drug Administration (FDA) regulates mifepristone, the more dangerous first drug of the two-part chemical abortion cocktail, via a Risk Evaluation and Mitigation Strategy (REMS), which limits how ...

U.S. Abortion Trends: 2019 and Preliminary 2020

As of September 1, 2021, there were 39 states that had released abortion statistics for 2019. Seventeen states reported a decline in abortions from 2018, while 21 states reported that abortions increased. One state, Wyoming, published its first abortion report for the latter half of 2019.

Strengthening the Pro-Life Safety Net: Childcare for Pregnant and Parenting Women in Need

Pregnant and parenting women in need (PPWIN) often face barriers to adequate childcare, including but not limited to trust, affordability, availability, location, and hours. Careful reform of federal programs serving low-income populations to improve PPWIN access to childcare, alongside a smarter al...

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepris...

New Abortion Trends in the United States: A First Look

To allow for a preliminary view of the current state of abortion in the U.S., the Charlotte Lozier Institute (CLI) reviewed all available state reports for 2017 and 2018. As of July 2020, 38 states had released 2018 abortion statistics. CLI’s preliminary review of 2017 state abortion reporting, pu...